What happens to intolerant, relapsed or refractory chronic...

  • Main
  • 2019 / 3
  • What happens to intolerant, relapsed or refractory chronic...
Hematology, Transfusion and Cell Therapy 2019 / 3

What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?

Bosi, Guilherme Rasia, Fogliatto, Laura Maria, Costa, Tito Emilio Vanelli, Grokoski, Kamila Castro, Pereira, Mariana Pinto, Bugs, Nathan, Kalil, Marco, Fraga, Christina, Daudt, Liane Esteves, Silla, L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Hematology, Transfusion and Cell Therapy
DOI:
10.1016/j.htct.2018.11.005
Date:
March, 2019
File:
PDF, 861 KB
english, 2019
Conversion to is in progress
Conversion to is failed